Publications & Media

Publications by The COVID-19 Global Rheumatology Alliance:

  • Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. [Epub ahead of print 29 May 2020]. doi: 10.1136/annrheumdis-2020-217871
  • Sirotich, E., Dillingham, S., Grainger, R., Hausmann, J.S. Capturing patient‐reported outcomes during the COVID‐19 pandemic: Development of the COVID‐19 Global Rheumatology Alliance Patient Experience Survey. Arthritis Care Res. [Epub ahead of print 9 May 2020]. doi:10.1002/acr.24257
  • Konig MF, Kim AH, Scheetz MH, et al. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Annals of the Rheumatic Diseases; [Epub ahead of print 7 May 2020]. doi: 10.1136/annrheumdis-2020-217690
  • Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology; [Epub ahead of print 6 May 2020]. doi: https://doi.org/10.1093/rheumatology/keaa191
  • Gianfrancesco, MA. Initial data from the COVID-19 Global Rheumatology Alliance provider registries – Authors’ reply. The Lancet Rheumatology; [Epub ahead of print 5 May 2020]. doi: doi.org/10.1016/S2665-9913(20)30125-9
  • Gianfrancesco, MA, et al. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. The Lancet Rheumatology; [Epub ahead of print 16 April 2020]. doi: https://doi.org/10.1016/S2665-9913(20)30095-3
  • Graef ER, Liew JW, Putman MS, et al. Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist. Annals of the Rheumatic Diseases; [Epub ahead of print 15 April 2020]. doi: https://doi.org/10.1136/annrheumdis-2020-217480
  • Robinson, PC, Yazdany, J. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Nat Rev Rheumatol; [Epub ahead of print 2 April 2020] doi: https://doi.org/10.1038/s41584-020-0418-0
  • Yazdany J, Kim AH. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Ann Intern Med; [Epub ahead of print 31 March 2020]. doi: https://doi.org/10.7326/M20-1334
  • Kim AH, Sparks JA, Liew JW, et al, for the COVID-19 Global Rheumatology Alliance. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med; [Epub ahead of print 30 March 2020]. doi: https://doi.org/10.7326/M20-1223

Mentions of The COVID-19 Global Rheumatology Alliance in Journals:

The COVID-19 Global Rheumatology Alliance in the Media: